Daily non-political popular news in brief.

Researchers urge caution in using ESAs for cancer-related anemia

05-01-2007 · EurekAlert!

Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.

Keywords: researchers, urge, caution, esas, cancer-related, anemia, researcher, esa, cancer, related

« Previous | Next »

Similar news on "Researchers urge caution in using ESAs for cancer-related anemia":

As personal genomics stands poised to go mainstream, researchers urge caution
09-20-2007 · EurekAlert!
Imagine this: you visit your clinician, undergo genetic testing and then you are handed a miniature hard drive containing your personal genome sequence, which is subsequently uploaded onto publicly accessible databases. This may sound like science fiction, but it is scientific fact, and it is already happening. In an article published in the journal Science, University of Alberta researcher Tim Caulfield and co-authors highlight the need to proceed cautiously when it comes to personal genomics.
Similar news · Read more »
Study suggests newer breast cancer drug may protect heart
06-08-2007 · EurekAlert!
By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Similar news · Read more »
Vet medicine researcher examines link between cancer, Down syndrome
02-04-2008 · EurekAlert!
There's new hope for breast cancer research, and it's coming from a very unlikely place. Researchers at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences recently published articles in the journals Molecular and Cellular Biology and Carcinogenesis indicating that a protein long suspected to play a role in Down Syndrome may also contribute to treating this devastating disease.
Similar news · Read more »
Drugs used to fight cancer-related bone problems boost odds of jaw- or face-bone disease
06-26-2007 · EurekAlert!
Treatment with intravenous bisphosphonates -- drugs used to reduce harm done to bones by cancer or cancer therapy -- increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found.
Similar news · Read more »
An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
10-08-2007 · EurekAlert!
Researchers have shed new light on how Kaposi's Sarcoma-associated Herpes Virus subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen (LANA) helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
Similar news · Read more »
Zinc transporters regulate pancreatic cancer
11-12-2007 · EurekAlert!
Zinc, an important trace element for healthy growth and development, can be related to pancreatic cancer. Too much ZIP4, a molecule that enables the transport of zinc into cells, promotes the growth and spread of pancreatic tumors cells, said a group of researchers from Baylor College of Medicine in Houston, the University of Texas M.D. Anderson Cancer Center and the University of Florida in Gainesville, in a report which appears online today in the Proceedings of the National Academy of Sciences.
Similar news · Read more »
Moving beyond tamoxifen: Drug discovery and the future of selective hormone receptor modulators
02-15-2008 · EurekAlert!
How did a failed contraceptive become the first targeted therapy for the treatment of breast cancer? The transformation of tamoxifen, from cast-off to lifesaver, laid the foundation for a new class of therapeutics -- selective estrogen receptor modulators. V. Craig Jordan, a researcher at the Fox Chase Cancer Center in Philadelphia, Jordan reports on efforts to use the lessons from tamoxifen to develop new hormone receptor-related drugs for both women and men.
Similar news · Read more »
Studies at cancer conference show new therapies changing outlook for blood cancer patients
12-08-2006 · EurekAlert!
The International Myeloma Foundation (IMF) -- conducting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians -- today noted that multiple studies presented at the 2006 Annual Meeting of the American Society of Hematology (ASH) illustrate the breadth of the gains being made in the treatment of multiple myeloma and related blood cancers.
Similar news · Read more »
New inhibitor has potential as cancer drug
10-22-2007 · EurekAlert!
Laboratory experiments have previously shown that cancer cells overproduce an enzyme, heparanase, which splits the body's own polysaccharide heparan sulfate into shorter fragments. The amount of enzyme is related to the degree of malignancy. Today a study is being published in the journal Nature Chemical Biology in which Uppsala University researchers show, on the basis of animal models, that an inhibitor for heparanase would be extremely interesting as a drug candidate.
Similar news · Read more »
Fighting diseases of aging by wasting energy
12-04-2007 · EurekAlert!
By making the skeletal muscles of mice use energy less efficiently, researchers report in the December issue of Cell Metabolism, a publication of Cell Press, that they have delayed the animals' deaths and their development of age-related diseases, including vascular disease, obesity, and one form of cancer. Those health benefits, driven by an increased metabolic rate, appear to come without any direct influence on the aging process itself, according to the researchers.
Similar news · Read more »